Quick Answer
Cyclerion Therapeutics, Inc. reported Net Income of -$3.53 million for fiscal year 2025.
Cyclerion Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$3.53M | -15.4% |
| 2024 | -$3.06M | +41.9% |
| 2023 | -$5.26M | +88.1% |
| 2022 | -$44.08M | +14.7% |
| 2021 | -$51.65M | +33.6% |
| 2020 | -$77.80M | +36.8% |
| 2019 | -$123.01M | -6.7% |
| 2018 | -$115.25M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$976.0K | -35.0% | -201.2% |
| June 30, 2025 | -$324.0K | +75.5% | +77.3% |
| March 31, 2025 | -$1.43M | +7.3% | -97.6% |
| September 30, 2024 | -$723.0K | -109.6% | +45.3% |
| June 30, 2024 | -$1.32M | +68.4% | +14.3% |
| March 31, 2024 | -$1.54M | +77.8% | -120.4% |
| September 30, 2023 | $7.57M | +172.1% | +281.0% |
| June 30, 2023 | -$4.18M | +68.8% | +39.9% |
- Cyclerion Therapeutics, Inc. showed a decrease of -15.4% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Cyclerion Therapeutics, Inc.’s net income has grown by 96.9% (from -$115.25 million to -$3.53 million).
- The most recent figure is from Cyclerion Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: